Most bioactive compounds in natural ingredients are thermolabile (heat-sensitive). Conventional high-temperature extraction often causes protein denaturation and degradation of pharmacological efficacy.
Low-Temperature Enzymatic Innovation
Royal Medica developed a specialized enzymatic fractionation methodology under strictly controlled temperatures (below 45°C). This process ensures pure albumin fractions and bioflavonoids remain completely intact.
Chromatography results demonstrate consistent active peptide profiles across production batches, delivering phytopharmaca preparations with superior bioavailability.
Related Product
View Product Details